Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “New Onset Type-1 Diabetes”

88 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 88 results

Testing effectiveness (Phase 2)Ended earlyNCT06025110
What this trial is testing

TCD601 (Siplizumab) in New Onset Type 1 Diabetes Patients

Who this might be right for
Diabetes Mellitus, Type 1
ITB-Med LLC 9
Testing effectiveness (Phase 2)WithdrawnNCT03794973
What this trial is testing

Diabetes Autoimmunity Withdrawn in New Onset Patients (DAWN)

Who this might be right for
Diabetes Mellitus, Type 1
Tolerion, Inc.
Large-scale testing (Phase 3)Ended earlyNCT05018585
What this trial is testing

A Phase III Study to Investigate if the Study Drug Diamyd Can Preserve Insulin Production and Improve Glycemic Control in Patients Newly Diagnosed With Type 1 Diabetes

Who this might be right for
Type 1 Diabetes Mellitus
Diamyd Medical AB 321
Large-scale testing (Phase 3)Not Yet RecruitingNCT07670650
What this trial is testing

PRISE (Personalized Response and Immunologic Surveillance of Endogenous C-Peptide Preservation in New, Recent, and Established Onset Type 1 Diabetes Treated With Human Anti-Thymocyte Globulin [h-ATG]) Study

Who this might be right for
Type 1 Diabetes (T1D)
University of Florida 108
Testing effectiveness (Phase 2)Study completedNCT02000817
What this trial is testing

Investigation of Otelixizumab in New-Onset, Autoimmune Type 1 Diabetes Mellitus Patients

Who this might be right for
Diabetes Mellitus, Type 1
GlaxoSmithKline 30
Testing effectiveness (Phase 2)Study completedNCT00100178
What this trial is testing

New Onset of Type 1 Diabetes Mycophenolate Mofetil-Daclizumab Clinical Trial

Who this might be right for
Diabetes Mellitus, Type 1
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 126
Not applicableStudy completedNCT06177691
What this trial is testing

Hybrid Closed Loop Therapy and Verapamil for Beta Cell Preservation in New Onset Type 1 Diabetes (CLVer): Extension Study

Who this might be right for
Type1 Diabetes
Jaeb Center for Health Research 77
Testing effectiveness (Phase 2)Study completedNCT00947427
What this trial is testing

Canakinumab Study in Individuals With Newly Diagnosed Type 1 Diabetes

Who this might be right for
Type 1 DiabetesPreservation of Insulin SecretionNewly Diagnosed Type 1 Diabetes+1 more
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 71
Large-scale testing (Phase 3)Study completedNCT01123083
What this trial is testing

Trial of Otelixizumab for Adolescents and Adults With Newly Diagnosed Type 1 Diabetes Mellitus (Autoimmune): DEFEND-2

Who this might be right for
Diabetes Mellitus, Type 1
GlaxoSmithKline 179
Testing effectiveness (Phase 2)Active Not RecruitingNCT05866536
What this trial is testing

Repeat BCG Vaccinations for the Treatment of New Onset Type 1 Diabetes in Children Age 8-<18 Years

Who this might be right for
Diabetes MellitusType 1 DiabetesDiabetes type1+1 more
Massachusetts General Hospital 100
Testing effectiveness (Phase 2)Study completedNCT02215200
What this trial is testing

ATG-GCSF in New Onset Type 1 Diabetes

Who this might be right for
Diabetes Mellitus, Type 1
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 89
Testing effectiveness (Phase 2)Study completedNCT04129528
What this trial is testing

Study of Safety and Efficacy of CFZ533 in Type 1 Diabetes Pediatric and Young Adult Subjects

Who this might be right for
Type 1 Diabetes Mellitus
Novartis Pharmaceuticals 44
Not applicableLooking for participantsNCT05767450
What this trial is testing

Intervention on New Onset-T1D Children

Who this might be right for
Type 1 Diabetes
IRCCS San Raffaele 60
Testing effectiveness (Phase 2)Study completedNCT01781975
What this trial is testing

Imatinib Treatment in Recent Onset Type 1 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type IDiabetes Mellitus, Insulin-Dependent, 1Type 1 Diabetes Mellitus+2 more
University of California, San Francisco 67
Testing effectiveness (Phase 2)Study completedNCT04774224
What this trial is testing

Baricitinib in New-onset Type 1 Diabetes

Who this might be right for
Type 1 Diabetes
St Vincent's Institute of Medical Research 91
Early research (Phase 1)Study completedNCT00545857
What this trial is testing

Effect of Pioglitazone on the Course of New Onset Type 1 Diabetes Mellitus

Who this might be right for
Type 1 Diabetes Mellitus
Stony Brook University 15
Not applicableEnded earlyNCT02605564
What this trial is testing

Effects of Gluten Free Diet on Type 1 Diabetes Mellitus in Children

Who this might be right for
Type 1 Diabetes Mellitus
Loma Linda University 18
Early research (Phase 1)Study completedNCT02971202
What this trial is testing

Contribution of Hyperinsulinemia vs. Hyperglycemia to Insulin Resistance in Type 1 Diabetes and Maturity Onset Diabetes of the Young, Type 2 (MODY2)

Who this might be right for
Type 1 Diabetes MellitusMaturity-Onset Diabetes of the Young, Type 2MODY2+1 more
Vanderbilt University 33
Testing effectiveness (Phase 2)Study completedNCT02005848
What this trial is testing

Phase II Study to Evaluate the Efficacy and Safety of Glassia® in Type-1 Diabetes

Who this might be right for
New Onset Type-1 Diabetes
Kamada, Ltd. 70
Large-scale testing (Phase 3)Study completedNCT04233034
What this trial is testing

Hybrid Closed Loop Therapy and Verapamil for Beta Cell Preservation in New Onset Type 1 Diabetes

Who this might be right for
Type1 Diabetes
Jaeb Center for Health Research 113
Next Page